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The complete degradation of N-linked glycans by the
pathogenic bacterium Streptococcus pneumoniae is
facilitated by the large multimodular cell wall-
attached exo-b-D-N-acetylglucosaminidase StrH.
Structural dissection of this virulence factor using
X-ray crystallography showed it to have two structur-
ally related glycoside hydrolase family 20 catalytic
domains, which displayed the expected specificity
for complex N-glycans terminating in N-acetylglu-
cosamine but exhibited unexpected differences in
their preferences for the substructures present in
these glycans. The structures of the two catalytic
domains in complex with unhydrolyzed substrates,
including an N-glycan possessing a bisecting N-ace-
tylglucosamine residue, revealed the specific archi-
tectural features in the active sites that confer their
differential specificities. Inhibitors of StrH are
demonstrated to be effective tools in modulating
the interaction of StrH with components of the host,
such as the innate immune system. Overall, new
structural and functional insight into a carbohy-
drate-mediated component of the pneumococcus-
host interaction is provided.
INTRODUCTION
Streptococcus pneumoniae, a notable human pathogen respon-
sible for over a million deaths annually, efficiently processes the
complex N-glycans of its human host (King, 2010; Tettelin et al.,
2001; Tomasz, 1999). Depolymerization of these intricate
N-glycan structures by S. pneumoniae requires various glyco-
side hydrolase activities. In general, glycoside hydrolases are
an enzyme superfamily that catalyze the hydrolytic cleavage of
glycosidic bonds and are currently classified into >125 amino
acid sequence based families (Cantarel et al., 2009). The
currently characterized pneumococcal N-glycan degradingStructure 19, 1603–16glycoside hydrolases fall into five families: GH33 (NanA), GH2
(BgaA), GH20 (StrH), GH85 (EndoD), and GH125. These
enzymes, all of which are considered virulence factors, are a
sialidase, exo-b-D-galactosidase, exo-b-D-N-acetylglucosami-
nidase, endo-b-D-N-acetylglucosaminidase, and an exo-a-D-
mannosidase, respectively, which work together to degrade
complex N-linked glycans (Abbott et al., 2009; Burnaugh et al.,
2008; Clarke et al., 1995; Gregg et al. 2011; Hava and Camilli,
2002; King et al., 2006). These enzymes have been proposed
to act as pneumococcal virulence factors for reasons ranging
from nutrient acquisition to modulation of the immune system
(Burnaugh et al., 2008; Dalia et al., 2010; King, 2010; Shelburne
et al., 2008).
Of the N-glycan processing pneumococcal enzymes StrH is
one of the least understood at themolecular level. Its importance
in the pneumococcus-host interaction is highlighted by the
observation that it is a demonstrated virulence factor in multiple
animal model screens for pneumonia or otitis media (Chen et al.,
2008; Hava et al., 2003). More recently, along with NanA and
BgaA, StrH has been shown to provide a protective effect
against the alternate pathway of complement mediated opsono-
phagocytic killing by neutrophils, which likely contributes, at
least in part, to the influence of the enzyme on pneumococcal
virulence (Dalia et al., 2010). StrH has long been known to hydro-
lyze the b(1-2) bond found linking a nonreducing terminal
N-acetyl-D-glucosamine (GlcNAc) to a mannose residue (Man)
in complex N-linked glycans (Yamashita et al., 1981). A more
detailed analysis by Clarke et al. (1995), which accompanied
the first identification and sequencing of the strH gene, found
that full-length StrH hydrolyzed terminal GlcNAc residues from
N-glycans without preference for whether it was found on the
a(1-3) or a(1-6) arm of the glycan; the enzyme tolerated
substrates having a bisecting GlcNAc. Additionally, it was shown
that a C-terminally truncated version of StrH no longer tolerated
a bisecting GlcNAc and thus possessed an altered substrate
preference compared to the full length enzyme. Despite the rele-
vance of StrH to the pneumococcus-host interaction and its
unique substrate specificity, insight into the molecular basis for
the specificity and activity of StrH is lacking. Furthermore, the
ambiguous aglycon specificity of the enzyme, a feature that
may be relevant to its biological role, remains unresolved.14, November 9, 2011 ª2011 Elsevier Ltd All rights reserved 1603
Figure 1. The Modular Architecture of StrH from S. pneumoniae
(Strain TIGR4)
Both catalytic modules are shown in black and the ‘‘unclassified’’ G5 modules
in white. The white and gray boxes at the N and C termini, respectively,
correspond the secretion signal and the LPXTG cell-wall anchoring motif.
Amino acid boundaries of the catalytic domains are indicated above the
schematic.
Structure
Structural Analysis of StrHAn examination of the primary structure of StrH shows it to be
a largemultimodular protein of 1312 amino acidswith a predicted
classical N-terminal Gram(+) secretion signal sequence, a
tandem of G5 modules of unknown function (Conrady et al.,
2008), and a C-terminal cell wall anchoring motif (LPXTG), which
is characteristic of a Gram(+) cell-wall attached protein (Figure 1)
(Schneewind et al., 1992). A unique feature of the enzyme is the
two predicted family 20 glycoside hydrolase catalytic domains
found toward the N-terminal end of the protein (Figure 1). The
presence of these linked catalytic modules considered in the
light of the ambiguous contribution of each of the two putative
catalytic modules to the specificity of StrH led us to postulate
that the catalytic modules would have subtly different specific-
ities for N-linked glycans. We approached this question through
a combination of X-ray crystallography and glycan microarray
screening of catalytically inactive variants of the isolated cata-
lytic modules. These results demonstrate differential specificity
of the two catalytic modules for the arms of complex N-glycans
and provide a unique look at an enzyme in complex with an
N-glycan having a bisecting b-1,4-linked GlcNAc residue. With
such structural information in hand we further hypothesized
that the identification and use of inhibitors that target StrH
may be used to intervene in its functions. Here we also demon-
strate that tight binding inhibitors of StrH can interfere in its
role in nutrient acquisition and its participation in protecting the
bacterium from the innate immune system. Overall, these results
provide new and detailed insight into the molecular basis of the
StrH-mediated interaction with its human host and how this
interaction may be modulated by inhibitors of this exo-b-D-N-
acetylglucosaminidase.
RESULTS AND DISCUSSION
The Recognition of N-Glycans by the Catalytic Modules
of StrH
The structural analysis of fragments of StrH (see below) allowed
the generation of constructs encoding the separate catalytic
modules of the enzyme, GH20A (residues 181–614) and
GH20B (residues 627–1039), which could be readily produced
in Escherichia coli. The activities of the two proteins were con-
firmed on 4-nitrophenyl-b-D-N-acetylglucosaminide, showing
both catalytic modules to be active and yielding Km values of
57.9 (±2.9) mM and 241.1 (±27.3) mM, respectively, and kcat
values of 4400 (±61) min1 and 1532 (±75) min1. The ability to
produce independent, functional GH20A and GH20B proteins
allowed us to probe the detailed specificity of these catalytic
polypeptides by first inactivating the proteins through mutation
of the catalytic acid/base residues (identified by structural anal-1604 Structure 19, 1603–1614, November 9, 2011 ª2011 Elsevier Ltdysis of the modules; see below) and then screening the binding
specificity of these mutants using glycan microarrays.
The mutants GH20AE361Q and GH20BE805Q bound exclu-
sively to N-glycans terminating in GlcNAc residues, reflecting
the known exo-b-D-N-acetylglucosaminidase activity of StrH.
GH20AE361Q bound to glycans when either the a(1-6) or
a(1-3) arms, but not both, of the glycans were capped with
GlcNAc (array samples 395 and 396, Figure 2). In contrast,
GH20BE805Q bound to a glycan with a terminal GlcNAc on
only the a(1-3) arm (array sample 396, Figure 2) but not a glycan
having a terminal GlcNAc on only the a(1-6) arm (i.e., it did not
bind to array sample 395, which has a blocked a[1-3] arm) (Fig-
ure 2). This indicates that GH20AE361Q is able to bind the
terminal GlcNAcb-1,2-Man motif on both the a(1-3) and a(1-6)
arms of a biantennary N-linked glycan whereas GH20BE805Q
can bind the same motif but only when it is present on the
a(1-3) arm. Interestingly, GH20AE361Q was unable to bind
a glycan having a terminal GlcNAc on the a(1-3) arm when the
a(1-6) arm was capped by both galactose and sialic acid (array
sample 306, Figure 2); GH20BE805Q showed no such restric-
tion. The basis of this is unclear but it does support the notion
that the optimal activity of StrH is promoted by complete prepro-
cessing of the complex glycan by NanA and BgaA.
GH20BE805Q also bound to a range of complex bisected
N-linked glycans, which are distinguished by the presence of
a GlcNAc residue found b-1,4-linked to the central mannose
residue (see glycan array samples 430–433, Figure 2), whereas
GH20AE361Q did not interact with any glycans having this bi-
secting GlcNAc residue. The ability of StrH to hydrolyze bisected
N-glycans, therefore, is most likely attributable to its GH20B
module. This is generally consistent with the observations of
Clarke et al. (1995) who had previously demonstrated that full-
length StrH has this activity but that a truncated version of
StrH, which corresponded approximately to the first catalytic
module, GH20A, is not able, even at high concentrations, to re-
move the GlcNAc residues from the arms of a bisected glycan.
Thus, GH20A and GH20B clearly differ not only in their abilities
to act on particular arms of biantennary glycans that terminate
in GlcNAc residues but they also differ in their abilities to process
bisected N-glycans.
The common recognition determinant in all of the glycans
against which GH20A and GH20B are active is the
GlcNAcb-1,2-Man disaccharide motif, which would occupy the
1 and +1 subsites of the GH20A and GH20B active sites (ac-
cording to the glycoside hydrolase subsite nomenclature [Davies
et al., 1997]). Based on the array results, however, GH20A and
GH20B must differ in their preference for portions of the glycans
that would interact with binding subsites extending beyond
the +1 subsite. To explore this hypothesis, the molecular basis
of glycan preference by GH20A and GH20B was pursued
through X-ray crystallographic analysis of the inactive mutant
proteins in complex with substrates.
Structural Analysis of the Catalytic Modules from StrH
Soluble protein and diffraction quality crystals were first obtained
for a construct comprising both of the (a/b)8 domains present in
StrH (called GH20A/B; residues 181–984; Figure 1). The 1.85 A˚
resolution structure obtained for this protein included 436 amino
acids, 434 of which corresponded to residues 181–615 of StrHAll rights reserved
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A B Figure 2. Glycan Binding Specificity of Inac-
tive GH20A and GH20B Mutants
Glycan microarray data is shown for (A)
GH20AE361Q and (B) GH20BE804Q. Each peak
that gives a substantial binding signal is repre-
sented as a vertical bar with error bars and
numbered corresponding to the glycan on the
microarray. Error bars represent the standard error
of the mean for quadruplicate measurements.
Schematic representations of the glycans for
which binding was observed is shown in (C). The
fluorescence signal is indicated below the glycan
for each protein. The fragments of glycans 52 and
430 representing the structures of GMMG and
NGA2B, respectively, are indicated in (C) by
shaded boxes.
Structure
Structural Analysis of StrH(Figure 3A). The model comprised an N-terminal (a/b)8 barrel
catalytic domain and a C-terminal three-helix bundle module
but lacked the expected (a/b)8 barrel of the GH20B catalyticStructure 19, 1603–1614, November 9, 2011 ªdomain. The close crystal packing and
lack of space for the GH20B domain indi-
cated that only a fragment of the recombi-
nant polypeptide was crystallized. This
result was then used to inform the accu-
rate modular boundaries of the GH20A
and GH20B constructs.
GH20A and GH20B crystallized allow-
ing their structures to be determined to
resolutions of 1.6 A˚ and 2.15 A˚, respec-
tively (Figure 3B). As expected from the
high amino acid sequence identity
between GH20A and GH20B (54%), the
overall structures of both polypeptides
are very similar (Figure 3B). Indeed, the
structural alignment of GH20A and
GH20B (a/b)8 barrels gives a small root-
mean-square deviation (rmsd) of 0.8 A˚
over 348 residues. Comparison of the
C-terminal three-helix bundles appended
to GH20A and GH20B (a/b)8 barrel do-
mains reveal them to be very similar with
a relatively low rmsd of 1.2 A˚ over 52 resi-
dues; however, they have slightly dif-
ferent dispositions relative to the catalytic
domains (Figure 3B). Though it is ap-
pended to the C terminus of the (a/b)8
barrel domain this a-helical domain ap-
pears to structurally replace the (a/b)
domain commonly found appended to
the N terminus of the (a/b)8 barrel do-
mains of other GH20 enzymes
(Figure 3C).
Family 20 glycoside hydrolases use a
substrate-assisted catalytic mechanism
that is orchestrated through a conserved
set of amino acid residues (Mark et al.,
2001; Tews et al., 1996). A structural
comparison of the GH20 domains fromStrH with other well-characterized family 20 glycoside hydro-
lases, which is typified by SpHex from Streptomyces plicatus
(Mark et al., 2001), reveals the conservation of these catalytic2011 Elsevier Ltd All rights reserved 1605
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Figure 3. Structural Analysis of StrH
(A) Secondary structure representation of the crystallized fragment of
GH20A/B, which corresponds to the GH20A module with its linker.
(B) Cartoon representations of GH20A (yellow) and GH20B (green) overlapped
and showing the slightly different dispositions of the a-helical linker domains.
(C) An overlap of GH20A with the family 20 glycoside hydrolase from
Streptomyces plicatus, SpHex, (Protein Data Bank [PDB] code 1HP5) showing
the similar catalytic domains (dark gray for GH20A and light gray for SpHex)
and their differing appended domains: the a-helical linker of GH20A is shown in
red and the a/b domain of SpHex in blue.
(D) An overlay of the active sites of GH20A (yellow), GH20B (green), and SpHex
(gray). The NGT bound to SpHex is shown in stick representation. The
conserved glutamate residue that acts as the general acid/base are shown as
sticks and labeled in the order from the top SpHex, GH20A, and GH20B. The
GH20 domain corresponds to an (a/b)8 barrel structure followed by a small
a-helical linker. The catalytic aspartate that interacts with the substrate
acetamido group is also shown in stick representation and labeled as for the
acid/base.
Structure
Structural Analysis of StrHresidues. Specifically, E361 in GH20A and E805 in GH20B act as
the putative acid/base and residues D360 and D804 in GH20A
and GH20B, respectively, aiding in positioning the acetamido
oxygen for nucleophilic attack on the anomeric carbon (Fig-
ure 3D). The ability to inactivate GH20A and GH20B catalytic
modules with E361Q and E805Q substitutions, respectively,
enabled the pursuit of substrate complexes with these
polypeptides.
The Structural Basis of N-Glycan Specificity
Complexes of GH20BE805Q were obtained by soaking crystals
with N-acetyl-D-glucosamine b-1,2-D-mannose a-1,3-D-man-
nose b-1,4-N-acetyl-D-glucosamine (GMMG) (Figure 2C) or
the bisected glycan N-acetyl-D-glucosamine b-1,2-D-mannose
a-1,3 (N-acetyl-D-glucosamine b-1,2-D-mannose a-1,6(N-
acetyl-D-glucosamine b-1,4))-D-mannose b-1,4-N-acetyl-D-1606 Structure 19, 1603–1614, November 9, 2011 ª2011 Elsevier Ltdglucosamine (NGA2B) (Figure 2C). Due to close crystal packing,
we were unable to soak large oligosaccharides into crystals
of GH20AE361Q, although complexes with the disaccharide
N-acetyl-D-glucosamine b-1,2-D-mannose (GM) were obtained
by this method. The GH20AE361Q with GM and GH20BE805Q
with GMMG complexes revealed clear electron density for the
carbohydrates allowing them to be completely modeled (Figures
4A and 4B). The carbohydrate in the GH20BE805Q with NGA2B
complex, however, could only be partially modeled as the a(1-6)
arm of the glycan was too disordered; the remainder of this
glycan, including the bisecting b-1,4-linked GlcNAc, could be
readily modeled (Figure 4C).
These complexes reveal 1 and +1 subsites that interact with
the terminal GlcNAc residue and the preceding b-1,2-linked
mannose residues through a conserved array of polar and apolar
interactions (Figures 4A–4C). Notably, as is most evident in the
1.75 A˚ resolution complex of GH20AE361Qwith GM, theGlcNAc
residue in the 1 subsite is distorted to adopt what has been
described as a ‘‘4-sofa’’ conformation and is very similar to
that observed in the Michaelis complexes of other glycoside
hydrolases that use a substrate-assisted catalytic mechanism
(Figure 4D) (He et al., 2010; Tews et al., 1996). The acetamido
group of this GlcNAc residue is positioned beneath the sugar
ring with the carbonyl oxygen (O7) positioned for nucleophilic
attack on the anomeric center (C1), a conformation that is partly
aided by the interaction of the amide nitrogen (N2) with the
carboxylate group of D360 (D804 in GH20B). Q361 (Q805 in
GH20B), which is a glutamate in the wild-type enzyme, is appro-
priately placed to act as a general acid/base and donate a proton
to the glycosidic oxygen. The distortion confers on the substrate
a conformation enabling the mannose residue to fit in the +1
subsite. In the absence of this distortion the mannose residue
would clash with the protein surface.
The1 subsites of GH20A andGH20B thus provide specificity
for terminal GlcNAc residues; however, the +1 subsites of
GH20A and GH20B make few specific interactions with the
bound mannose residue (Figures 4A–4C) suggesting that this
subsite makes little specific contribution to substrate recogni-
tion. An examination of GH20B in complex with GMMG indicates
that interactions beyond the1 and +1 subsites provide both the
general specificity of GH20B for N-linked glycans and its selec-
tivity for the a(1-3) arm on these glycans. The glycosidic bond of
the Manb1-4GlcNAc motif in GMMG is centered over the indole
side chain of W876 resulting in the parallel alignment of the
b- and a-faces of the Man and GlcNAc residues, respectively,
with the aromatic ring (Figures 4B and 5A). Furthermore, an addi-
tional tryptophan residue, W877, right at the entrance to the
GH20B active site appears to be suitably positioned to interact
with the b-face of an additional GlcNAc residue (Figure 5A),
which would be the GlcNAc residue of the chitobiose core teth-
ering the N-linked glycan to a protein. Thus, this aromatic ramp
into the active site of GH20B provides extensive interactions
with a larger N-glycan. This set of interactions also appears to
provide unique specificity for the a(1-3) arm of the glycan, which
was revealed by generating a model of GH20B in complex with
the a(1-6) arm of an N-glycan (Figure 5B). The three principle ro-
tamers of a biantennary complex N-glycan having terminal
GlcNAc residues were generated with GLYCAM (Kirschner
et al., 2008). These were positioned in the active site based onAll rights reserved
Figure 4. Architecture of the Catalytic Sites of
GH20A and GH20B
(A) GH20AE361Q complexed with GM.
(B and C) GH20BE805Q complexed with GMMG and
NGA2B, respectively. Key residues in the catalytic site are
shown in green. In (A–C) relevant amino acids in the active
site and the carbohydrate are shown stick representation
with the carbohydrate colored in salmon. Potential
hydrogen bonds are indicated as black dashed lines and
the subsites are labeled 1, +1, +10.
(D) An isolated view of GM complexed with GH20AE361Q
showing the distortion of the GlcNAc residue in the 1
subsite and proximity of the catalytic residues. All panels
are shown in divergent stereo. See also Figure S1.
Structure
Structural Analysis of StrHthe orientation and conformation of the mannose in the +1 active
site; two of the modeled complexes were excluded as improb-
able on the basis of extreme clashes between the sugar andStructure 19, 1603–1614, November 9,the active site. The third model gave a plausible
fit of the sugar in the active site, without steric
clashes, that did not require manipulation of
the sugar conformation. In this model the central
mannose residue is positioned in the center of
the active site cleft with its a-face oriented
toward the face of the W876 side chain. This
results in an unfavorable situation where the
axial O2 hydroxyl of the mannose is directed
toward the indole ring ofW876 and sominimizes
the formation of favorable C-H:p interactions.
Furthermore, the GlcNAc residue that precedes
this mannose residue is directed out of the
active site where it makes no additional interac-
tions. This suggests that the unique conforma-
tion of the a(1-6) arm precludes favorable
binding to the enzyme and that the architecture
of the GH20B active site selectively recognizes
only the a(1-3) arm of N-glycans.
GH20A possesses a different active site
architecture in the region distal to the 1 and
+1 subsites. W443 is conserved with W876 of
GH20B and forms one wall of the active site.
On the opposing side of the GH20A active site
is W481, which has no equivalent in GH20B.
This creates an ‘‘aromatic clamp’’ in the active
site of GH20A (Figure 5C), which we postulate
confers the ability of this catalytic domain to
recognize both arms of an N-glycan. A model
of GH20A in complex with GMMG, which is
simply based on an overlay of the GH20B struc-
ture in complex with this glycan, reveals a set of
interactions with W443 that is identical to that
observed between the glycan and W876 in
GH20B (Figure 5D). A model of GH20A in
complex with the a(1-6) arm, which was gener-
ated as described for GH20B, shows only the
same glycan rotamer can be plausibly accom-
modated in the active site (Figure 5D). As seen
in the GH20B model, the a-face of the central
mannose residue is unfavorably oriented towardW443; however, in this case, the b-face of the mannose residue
is parallel with the side chain of W481 and with an appropriate
disposition to suggest that favorable C-H:p interactions may2011 ª2011 Elsevier Ltd All rights reserved 1607
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Figure 5. Surface Representation of the Catalytic Sites of the Catalytic Modules from StrH
(A) Surface representation of GH20B with GMMG bound in the catalytic groove. GMMG is shown in pink stick representation. The location the a(1-6) arm would
have in the active site is shown with an arrow.
(B) Surface representation of GH20B with GMMG bound in the catalytic groove (pink) and a modeled biantennary glycan (green) with the a(1-6) arm in the active
site. The central mannose residue and core GlcNAc residue are shown in thick stick representation. GMMG is shown in pink stick representation. The a(1-3) arm
of the modeled glycan is labeled.
(C) Surface representation of GH20A with GM bound in the catalytic groove. GM is shown in pink stick representation.
(D) Surface representation of GH20A with GMMG modeled into the catalytic groove (pink) and a modeled biantennary glycan (green) with the a(1-6) arm in the
active site. The central mannose residue and core GlcNAc residue are shown in thick stick representation. The a(1-3) arm of the modeled glycan is labeled.
(E) Surface representation of GH20B with NGA2B bound in the catalytic groove. The surface of the +10 subsite is colored blue.
(F) Structural alignment of GH20A (in yellow) and GH20B (in green). NGA2B is shown in pink stick representation. The red circle highlights the main difference
between the two catalytic sites. GH20A residues are indicated and those of GH20B in brackets. In all panels, subsites are labeled 1, +1, or +10. In (A–E) the
purple surfaces represent key aromatic residues in the active sites.
Structure
Structural Analysis of StrHbe made. No such interaction is possible in GH20B. Thus, the
aromatic clamp in the GH20A active site appears uniquely
configured to recognize both arms of complex N-glycans by
being able to accommodate the different positioning of the
mannose residue that precedes the +1 subsite.
The importance of the aromatic residues in the plus (+)
subsites in substrate recognition were further probed by making
alanine substitutions ofW443,W481, and Y482 inGH20A,W876,
and W877 in GH20B. The Km of these mutants was determined
for 4-nitrophenyl-b-D-N-acetylglucosaminide as a measure of
substrate recognition. The structurally analogous tryptophan
residues of W443 and W876 in GH20A and GH20B gave Km
values of 489.2 (±28.5) mMand 1783.0 (±146.3) mM, respectively,
representing 7–8-fold increases relative to the native catalytic
modules and thus demonstrating the importance of these resi-
dues in recognizing the aryl-glycoside substrate. The W877A
mutation of GH20B gave a Km of 376.2 (±26.3) mM, which is rela-
tively insignificant 1.5-fold change over GH20B; this likely
reflects the fact that the side chain of W877 is on the outer
edge of the GH20B active site and the nitrophenyl group of the
substrate does not interact with this side chain. Surprisingly,
theW481A and Y482A substitutions in GH20A resulted in relative
small 1.4-fold (Km 80.6 [±26.3] mM) and 2.8-fold (Km 162.0 [±12.5]
mM) changes in Km, respectively, relative to GH20A. This1608 Structure 19, 1603–1614, November 9, 2011 ª2011 Elsevier Ltdsuggests that they are not important in the recognition of the ni-
trophenyl group of this particular substrate. However, this does
not discount the possible importance of these side chains in
recognizing larger and more complex substrates, such as is
postulated for the a-1,6-arm of an N-glycan. Indeed, as sug-
gested by the complex of GH20A with GM, the 4-nitrophenyl-
b-D-N-acetylglucosaminide is likely too small to extend far
enough to interact substantially with the side chains of W481
and Y482.
The differences in active site architecture beyond the 1
and +1 subsites contribute to the general specificities of
GH20B and GH20A for N-linked glycans and to their subtly
different preferences for the arms of these glycans. This also
applies to the ability of GH20B to recognize bisected N-linked
glycans, the molecular basis of which is elegantly linked to the
same active site features that result in selectivity for the arms
of the glycans. The complex of GH20BE805Q with NGA2B
shows the b-1,4-linked bisecting GlcNAc to fit in a relatively
apolar +10 subsite with the rest of the sugar chain positioned
identically to that in the GMMG complex (Figure 5E). The protein
only makes one potential hydrogen bond with the bisecting
GlcNAc (not shown) but the pocket fits quite snugly around the
GlcNAc residue. The structural alignment of GH20A and
GH20B shows that the side chains of W481 and Y482 fill whatAll rights reserved
Table 1. Inhibitor Binding Parameters Determined by Inhibition
Constants (Ki) and Isothermal Titration Calorimetry (Kd)
GH20A GH20B
Ki NGT (mM) 1.0 (±0.1) 2.7 (±0.2)
PUGNAc (nM) 0.8 (±0.1) 381.8 (±64.7)
Kd NGT (mM) 1.0 (±0.1) 1.3 (±0.3)
PUGNAc (nM) NDa 90.2 (±8.8)
aND, not determined as the Kd was too small to determine by this
method. See also Figure S2 and Figure S3.
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Structural Analysis of StrHwould be the +10 subsite in GH20A preventing a sugar residue
from binding. In contrast, glycine residues at the analogous posi-
tions in GH20B (residues 913 and 914) results in a wider opening
of the catalytic groove and the formation of a +10 subsite that can
accommodate a sugar residue (Figure 5F). The same active site
features that appear to enable GH20A to recognize the a(1-6)
arm of an N-glycan, i.e., the presence of W481, therefore also
influences the inability of this catalytic domain to recognize
bisecting N-glycans, which in turns offers a rationale for the
duplicate GH20 domains within StrH.
The modular architecture of StrH suggests a gene duplication
and fusion to generate a gene encoding a protein with repeated
catalytic modules. The primary function of the two catalytic
modules is clearly to hydrolyze terminal GlcNAc residues that
are b(1-2) linked to mannose residues. Given this apparently
identical basic role it is difficult to rationalize the evolutionary
retention of the repeated catalytic domains. The results obtained
here reveal that the two catalytic domains in StrH, GH20A, and
GH20B, possess different specificities and that the structural
features that impart these specificities appear to be mutually
exclusive. This suggests that it may be impossible for a single
catalytic domain to provide the expanded substrate range that
is required of StrH or, alternatively, that the simplest evolutionary
solution is the presence of two domains that have coevolved
to provide a working pair with the necessary substrate range.
These data further suggest that loss of one domain would
compromise the fitness of S. pneumoniae in the host, perhaps
by preventing StrH from targeting a wide range complex
N-glycans, including the bisected variety such as those that
are not only abundant on immunoglobulins but are often impor-
tant to optimal Ig function (Arnold et al., 2007).
Inhibition of StrH Potentiates Opsonophagocytic Killing
of S. pneumoniae
With increasing evidence that glycoside hydrolases are impor-
tant in the host-bacterium interaction, the possibility of modu-
lating this relationship using glycoside hydrolase inhibitors is
attractive. The pneumococcal neuraminidases, primarily NanA,
have been the subject of intense research in this area as influ-
enza anti-virals that target the viral neuraminidase have also
been beneficial in suppressing the role of the pneumococcal
neuraminidases both in vitro and in vivo (Gut et al., 2011; Parker
et al., 2009; Trappetti et al., 2009). Such inhibitors have also
proven useful as chemical probes of enzyme function, providing
the potential to support results obtained with mutant strains
where genes have been deleted or inactivated. In this light, we
explored the identification and characterization of StrH inhibitorsStructure 19, 1603–16for the purposes of probing StrH function in assays that model
aspects of the pneumococcus-host interaction. 1,2-dideoxy-
20-methyl-a-D-glucopyranoso [2,1-d]-d20thiazoline (NGT)
(Knapp et al., 1996) and O-(2-acetamido-2-deoxy-D-glucopyra-
nosylidene)amino-N-phenylcarbamate (PUGNAc) (Horsch et al.,
1991) are both well-known inhibitors of N-acetylglucosamini-
dases; the interaction of these inhibitors with GH20A and
GH20B was studied by the determination of kinetic inhibition
constants (Ki) and dissociation constants (Kd) determined by
isothermal titration calorimetry.
The Ki and Kd values for NGT binding to both of the polypep-
tides were comparable and in the range of 1–2 mM (Table 1),
which is roughly an order of magnitude larger than the Ki values
determined for other family 20 glycoside hydrolases (Langley
et al., 2008). PUGNAc was tighter binding showing Ki and Kd
values in the 1–400 nM range (Table 1). Although GH20A and
GH20B bound NGT equally well, the two proteins showed
notably different affinities for PUGNAc as reflected by the
400-fold lower Ki for GH20A relative to GH20B.
With efficient inhibitors in hand we postulated that these could
be used to chemically recapitulate a DstrH phenotype and thus
demonstrate the potential utility of such inhibitors for studying
the function of StrH. A strain of S. pneumoniae 6A-T with its
strH gene deleted was reported to grow poorly on the N-glyco-
sylated human a-1 glycoprotein and thus the ability of
S. pneumoniae to grow on N-glycans has partly been attributed
to StrH activity (Burnaugh et al., 2008). We therefore tested the
effect of PUGNAc inhibition of StrH in a nutrient acquisition
model using asialofetuin, a readily available glycoprotein protein
bearing complex N-glycans, as the nutrient supply. Compared
to wild-type S. pneumoniae TIGR4, a DstrH strain showed sup-
pressed growth on asialofetuin to 65% of the wild-type, which
was entirely consistent with previous observations (Burnaugh
et al., 2008) (Figure 6A). The addition of PUGNAc at 100 nM
to wild-type cultures produced a phenotype identical to that of
the DstrH strain (65% of wild-type growth; Figure 6A) whereas
increasing concentrations of PUGNAc resulted in dose-
response of decreasing growth with increasing inhibitor and
allowed estimation of the half-maximal effective concentration,
EC50, to be 33 nM (Figure 6B), thus demonstrating the ability
to modulate StrH activity in bacterial culture using small mole-
cule chemical inhibitors.
Nutrient acquisition is one likely role that StrH has in the
host-bacterium interaction. However, NanA (sialidase), BgaA
(exo-b-D-galactosidase), and StrH were also recently shown to
have a function in protecting S. pneumoniae from opsonophago-
cytic killing by the alternate pathway of complement activation
(Dalia et al., 2010). This role in immune evasion is another likely
contribution of these enzymes to the virulence of the pneumo-
coccus. The ability to complement the DnanA strain in trans
with recombinant NanA generally suggests it is the catalytic
activity of this enzyme that is responsible for the interaction
with the complement pathway; however, this postulate currently
lacks additional support. Expansion of this assumption to
include BgaA and StrH is reasonable but also lacks any support-
ing experimental evidence. Indeed, in the case of StrH, the three-
helix bundle modules that follow the (a/b)8 domains in both
GH20A and GH20B but do not play a role in substrate recogni-
tion have significant structural identity with the staphylococcal14, November 9, 2011 ª2011 Elsevier Ltd All rights reserved 1609
Figure 6. PUGNAc Inhibits the Growth of S. pneumoniae (TIGR4) on
Asialofetuin
(A) Growth curves performed using a semi-defined medium supplemented
with asialofetuin. Closed circles represents growth of the wild-type strain,
open circles the growth of wild-type strain in the presence of 100 nMPUGNAc,
and closed squares the growth of the Dstrh strain. The experiment was per-
formed multiple times with identical results. A represented experiment with
measurements made in triplicate is shown with error bars representing the
standard deviation of measurements made from growth cultures performed in
triplicate.
(B) Inhibition of growth on asialofetuin as a function of PUGNAc concentration.
Results represent the mean measurements of three independent experiments
where culture densities were taken after 10 hr of growth. The error bars
represent the standard deviations of the independent measurements. Time
concentration of PUGNAc required to reduce growth by 50% (EC50) was
estimated from this graph to be 33 nM.
Figure 7. Inhibitors of Strh Increase Opsonophagocytic Killing of
S. pneumoniae
Survival of S. pneumoniae TIGR4 in neutrophil killing assays, showing
comparisons of wild-type (filled bars) and Dstrh strain (open bars) in the
presence and absence of NGT or PUGNAc. Asterisks above sample bars
represent statistical comparison of that sample with the reference, which is the
TIGR4 strain with no inhibitor. Statistical differences were analyzed by
unpaired Student’s two-tailed t test. Data are mean values compiled from two
independent experiments performed in duplicate ± standard error of themean.
*p < 0.05; **p < 0.01; ***p < 0.001. The Dstrh samples with inhibitors were
compared with Dstrh in the absence of inhibitors and were found to have
p values >0.1 and thus were not significantly different.
Structure
Structural Analysis of StrHcomplement inhibitor (SCIN) protein (rmsd 1.9 A˚ over 59 Cas;
14% amino acid sequence identity). In S. aureus SCIN functions
as an inhibitor of C3 deposition by binding C3 and preventing
formation of the C3:convertase complex, thus ultimately protect-
ing the bacterium from complement mediated bacterial clear-
ance (Garcia et al., 2010). It is plausible that the SCIN-like
modules in StrH could perform a similar function, but this is1610 Structure 19, 1603–1614, November 9, 2011 ª2011 Elsevier Ltda possibility that could not be resolved solely by the study of
the DstrH strain. Having established the ability to inhibit that
activity of StrH in bacterial cultures and prevent its role in nutrient
acquisition, we reasoned that the application of these inhibitors
in opsonophagocytic killing assays would lend insight into
whether the interaction of StrH with the complement system is
directly due to its catalytic activity.
As previously observed, the survival of the DstrH strain was
30% of the parent TIGR4 strain (Dalia et al., 2010) (Figure 7).
The addition of 5 mM or 50 mM of NGT to assays performed
with the TIGR4 strain reduced the survival of the bacterium rela-
tive to the TIGR4 strain to50%. Likewise, the addition of 50 nM
or 50 mM PUGNAc reduced the survival of the bacterium to 65%
and 55%, respectively. Off-target effects were assessed by per-
forming the same inhibitor experiments with the DstrH strain; the
survival rates in these experiments were not significantly
different from that obtained with DstrH strain in the absence of
inhibitor. Thus, it appears that the protective effect of StrH
against opsonophagocytic killing of the bacterium can be specif-
ically reduced by compounds that inhibit the activity of the
enzyme to survival rates that are not statistically different than
that for the strain lacking the strH gene. Though we cannot
unequivocally rule out off-target effects of the inhibitors on
neutrophil enzymes, these observation are consistent with the
requirement of accessible active sites in the StrH catalytic
modules to provide its protective effect against complement
mediated killing of the bacterium and supports that hypothesis
that the hydrolytic activity of StrH is also required.All rights reserved
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Structural Analysis of StrHStrH is a complex multimodular protein that is newly revealed
to have two functional catalytic domains that display subtly
different specificities for GlcNAc terminating N-linked glycans.
The differential specificities of these catalytic domains highlights
the complexity of the protein and supports the growing evidence
that this protein and other pneumococcal glycoside hydrolases
have a multifaceted role in the host-pneumococcus interaction.
With respect to StrH, this interaction can now be understood
and interpreted at the molecular level. Furthermore, the ability
to manipulate the StrH-mediated interaction with host-compo-
nents using inhibitors continues to support the examination of
glycoside hydrolase inhibitors as tools to study the pneumo-
coccus-host interaction and adds weight to consideration of
such inhibitors as a potential therapeutic strategy.
EXPERIMENTAL PROCEDURES
Materials
Oligosaccharides were obtained from V-Labs (Covington, LA). The tetrasac-
charide N-acetyl-D-glucosamine b-1,2-D-mannose a-1,3-D-mannose b-1,4-
N-acetyl-D-glucosamine (here referred to as GMMG) was synthesized as
described previously (Parsons et al., 2009). All other reagents and chemicals
were purchased from Sigma unless otherwise specified.
Cloning
Gene fragments encoding both GH20A and B modules (GH20A/B, amino
acids 181-984) and the individual GH20 catalytic modules (GH20A, residues
181-614; GH20B, residues 627-1039) were amplified by PCR from
S. pneumoniae TIGR4 genomic DNA (American Type Culture Collection
BAA-334D) using specific primers to introduce a 50 NdeI and 30 XhoI restriction
sites (see Table S1 available online for oligonucleotide primer sequences).
Site-directed mutations were introduced using the ‘‘megaprimer’’ PCR
method (Table S1) (Barik, 1996). The resulting gene fusions encoded aN-termi-
nal six-histidine tag fused to the protein of interest by an intervening thrombin
protease cleavage site. Bidirectional DNA sequencing was used to verify the
fidelity of each construct.
Protein Expression and Purification
All recombinant expression vectors were transformed into E. coli BL21 Star
(DE3) cells (Invitrogen) and proteins were produced using LB medium supple-
mentedwith kanamycin (50 mg3ml1). Briefly, bacterial cells transformedwith
the appropriate expression plasmid were grown at 37C until the culture
reached an optical density of 0.8–0.9 at 600 nm. Gene expression and protein
production was then induced by the addition of isopropyl b-D-1-thiogalacto-
pyranoside (IPTG) to a final concentration of 0.5 mM; incubation was
continued overnight at 16C with shaking. Cells were harvested by centrifuga-
tion and disrupted by chemical lysis. Proteins were purified from the cleared
cell-lysate by Ni2+-immobilized metal affinity chromatography followed by
size exclusion chromatography using a Sephacryl S-200 column (GE Health-
care). Purified protein was concentrated using a stirred-cell ultrafiltration
device with a 10 K molecular weight cut-off membrane (Millipore).
Protein concentration was determined by measuring the absorbance at
280 nm and using calculated molar extinction coefficients of 147,490 cm1 3
M1 for GH20A/B, 71,740 cm1 3 M1 for GH20A and GH20AE361Q, and
78,730 cm1 3 M1 for GH20B and GH20BE805Q (Gasteiger et al., 2003).
Glycan Microarray Binding Assays
Proteins for glycan array screening were complexed with fluorescein isothio-
cyanate (FITC)-labeled Streptavidin (Invitrogen) via a biotin-NTA linker (Bio-
tium) according to the following protocol. Two milligrams of biotin-NTA and
2 mg of FITC-streptavidin were mixed together in 20 mM Tris-HCl, pH 8.0,
with 2mMNiSO4. Thismixture was loaded on a gel filtration column (Sephacryl
S-200 HR) and the fractions corresponding to the complex were pooled and
concentrated. The FITC-streptavidin complex was added to the protein of
interest in a molar ratio 1:2 (labeling complex: protein) in 20 mM Tris-HCl,Structure 19, 1603–16pH 8.0. Finally, the protein complexes at 180–200 mg ml1 were used to probe
the printed glycan arrays (mammalian glycan array version 4.1) following the
standard procedure of CoreH of the Consortium for Functional Glycomics
(http://www.functionalglycomics.org/).
General Crystallography Procedures
Crystals were obtained using sitting-drop vapor diffusion for screening and
hanging drop vapor diffusion for optimization, all at 18C. For data collection
single crystals were flash cooled with liquid nitrogen in crystallization solution
supplemented with a cryoprotectant optimized for each crystal form as given
below. Diffraction date was collected either on a ‘‘home-beam’’ comprising
a Rigaku R-AXIS 4++ area detector coupled to a MM-002 X-ray generator
with Osmic ‘‘blue’’ optics and an Oxford Cryostream 700, Beamline 9-2 of
the Stanford Linear Accelerator Center (SLAC, Stanford Synchrotron Radiation
Lightsource [SSRL], CA), or CMCF1 at the Canadian Light Source (CLS,
Saskatoon, Saskatchewan) as indicated in Table 2. All diffraction data was
processed using MOSFLM and SCALA (Collaborative Computational Project,
1994; Powell, 1999). All data collection and processing statistics are shown in
Table 2. For all structures, manual model building was performed with COOT
(Emsley and Cowtan, 2004) and refinement of atomic coordinates was per-
formed with REFMAC (Murshudov et al., 1997). The addition of water mole-
cules was performed in COOT with FINDWATERS and manually checked after
refinement. In all data sets, refinement procedures were monitored by flagging
5% of all observation as ‘‘free’’ (Bru¨nger, 1992). Model validation was per-
formed with SFCHECK (Vaguine et al., 1999), PROCHECK (Laskowski et al.,
1993), and MOLPROBITY (Davis et al., 2007). All model statistics are shown
in Table 2. Coordinates and structure factors have been deposited with the
PDB codes of 2yll for the GH20A/B iodide derivative, 2yl6 for GH20A, 2yl8
for GH20A361Q with GM, 2yl5 for GH20B, 2yl9 for GH20BE805Q with
GMMG, and 2yla for GH20BE805Q with NGA2B.
GH20A/B Structure Determination
Crystals of GH20A/B (20 mg3ml1) were obtained in 20% (w/v) polyethylene
glycol (PEG) 3350, 0.4M potassium bromide, 0.1M Tris-HCl, pH 8.2. An iodide
derivative was obtained by soaking a crystal in crystallization solution contain-
ing 25% (v/v) ethylene glycol and 1 M sodium iodide for 2 min prior to data
collection. A heavy atom substructure for the GH20A/B NaI derivative com-
prising 20 iodide atoms was determined using ShelxC/D and initial phasing
was performed using the ShelxE (Sheldrick, 2008). Additional phase improve-
ment was done with DM using an estimated solvent content of 45% (Cowtan
and Main, 1993). An initial model of 50% completeness was automatically
constructed using BUCANNEER (Cowtan, 2006). This model and the set of
iodide atoms located with ShelxD were used for SAD-MR phasing in PHASER
(McCoy et al., 2007) followed by phase improvement with DM. The resulting
phases were of sufficient quality for ARP/warp (Cohen et al., 2008) to build
a virtually complete model with docked side chains. The final heavy atom
substructure was determined by examination of anomalous difference maps.
GH20A Structure Determination
Crystals of GH20A (25 mg 3 ml1) were grown in 20% (w/v) PEG 3350, 0.4 M
potassium bromide, 0.1 M Tris-HCl, pH 8.2, although this protein crystallized
in a variety of PEG3350 concentrations, salts, andpHs. Adata setwas collected
as above on a single crystal that was cryoprotected in crystallization solution
supplemented with 20% (v/v) ethylene glycol. Crystals of GH20AE361Q
(25mg3ml1)wereobtained in20%(w/v)PEG3350,0.2Mmanganesechloride
and 0.1 M sodium cacodylate, pH 6.8. These crystals were soaked for 20min in
the crystallization solution containing an excess of GM prior to freezing using
20% (v/v) ethylene glycol in crystallization solution as a cryoprotectant. The
model built with the GH20A/B NaI derivative data was used to solve the struc-
tures of GH20A and GH20AE361Q by molecular replacement using PHASER.
GH20B Structure Determination
Crystals of GH20B (20 mg 3 ml1) were obtained in 17% (w/v) PEG 3350,
0.22 M magnesium chloride and 0.1 M Tris-HCl, pH 7.5. A native data set
was collected using 15% (v/v) ethylene glycol as a cryo-protectant. Crystals
of GH20BE805Q were grown in 20% PEG 3350, 0.22 M magnesium chloride
and 0.1 M Tris-HCl, pH 7.5, and soaked for 20 min with the crystallization
solution containing >5 mM of GMMG or NGA2B. Crystals were frozen in14, November 9, 2011 ª2011 Elsevier Ltd All rights reserved 1611
Table 2. X-Ray Data Collection and Structure Statistics for Native and Substrate Complexes
GH20A GH20B
Iodide Derivative
(GH20A/B) Native
E361Q Mutant
with GM Native
E805Q Mutant
with GMMG
E805Q Mutant
with NGA2B
Data collection
Beamline MM-002 MM-002 SSRL BL9-2 SSRL BL9-2 SSRL BL9-2 CLS CMCF1
Wavelength (A˚) 1.54180 1.54180 0.97915 0.97903 0.97884 0.98400
Space group I222 I222 I222 P21 P21 P21
Cell dimensions
a, b, c (A˚) 78.5, 109.4,
112.4
78.3, 109.0,
112.4
78.6, 109.3,
112.9
67.3, 115.9,
132.3 (b = 99.6)
67.27, 115.9,
132.4 (b = 99.5)
67.6, 115.7,
132.2 (b = 99.7)
Resolution (A˚) 20.00–1.85 19.93–1.60
(1.66–1.60)
35.60–1.75
(1.84–1.75)
38.63–2.15
(2.27–2.15)
46.61–2.65
(2.79–2.65)
30.00–2.70
(2.85–2.70)
Rmerge 0.087 (0.379) 0.063 (0.353) 0.091 (0.397) 0.136 (0.385) 0.135 (0.392) 0.151 (0.276)
<I/sI > 25.2 (7.2) 11.7 (3.1) 20.4 (4.4) 10.4 (3.5) 8.5 (3.5) 8.9 (4.6)
Completeness (%) 99.9 (100) 94.00 (85.5) 100 (100) 97.1 (93.0) 95.4 (88.9) 99.9 (100)
Redundancy 16 (15.4) 3.9 (3.4) 8.0 (8.0) 4.8 (4.2) 4.8 (4.7) 4.3 (4.3)
Reflections (n) 664,283 231,908 393,811 502,698 269,149 234,561
Unique (n) 41,605 59,835 49,280 105,278 55,642 55,076
Refinement
Resolution (A˚) 1.85 1.60 1.75 2.15 2.65 2.7
Rwork/Rfree 0.16/0.20 0.19/0.22 0.16/0.21 0.24/0.28 0.23/0.30 0.22/0.27
Atoms (n)
Protein 3425 3618 3571 3320 (A), 3340 (B),
3343 (C), 3282 (D)
3269 (A), 3258 (B),
3271 (C), 3269 (D)
3321 (A), 3317 (B),
3267 (C), 3261 (D)
Ligand 68 (IOD), 2 (CA),
24 (PEG), 8 (EDO)
2 (MG),
40 (EDO),
14 (PEG)
9 (MN), 4 (EDO),
33 (PEG),
26 (MAN-NAG)
10 (MG),
52 (EDO)
51 (F), 51 (G),
51 (H), 51 (E),
181 (EDO)
65 (F), 65 (G), 51 (H),
65 (E), 60 (EDO)
Water 595 628 648 2330 818 794
B-factors
Protein 12.4 16.4 12.50 8.8 (A), 19.4 (B),
9.6 (C), 20.6 (D)
15.0 (A), 14.9 (B),
14.6 (C), 16.3 (D)
14.1 (A), 13.7 (B),
12.7 (C), 14.9 (D)
Ligand 31.4 (IOD),
17.4 (CA),
61.8 (PEG),
17.3 (EDO)
21.3 (MG),
38.0 (EDO),
41.5 (PEG)
35.7 (MN),
15.8 (EDO),
35.1 (PEG),
14.5 (MAN-NAG)
13.0 (MG),
27.0 (EDO)
58.2 (F), 60.0 (G),
61.3 (H), 52.6 (E),
36.7 (EDO)
62.5 (F), 68.9 (G),
56.7 (H), 59.1 (E),
41.9 (EDO)
Water 26.9 30.9 27.0 26.0 11.9 14.1
Rmsd
Bond lengths (A˚) 0.010 0.009 0.015 0.005 0.006 0.006
Bond angles () 1.137 1.073 1.425 0.802 0.936 1.005
Ramachandran (%)
Preferred 98.2 98.4 97.9 96.3 95.8 95.3
Generously allowed 1.8 1.6 2.1 2.7 4.1 4.6
Disallowed 0 0 0 0.1 0.1 0.1
Values for highest resolution shells are shown in parenthesis. Rmsd, root-mean-square deviation.
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Structural Analysis of StrHcrystallization solution supplemented with 15% (v/v) ethylene glycol. The
structure of GH20B was determined bymolecular replacement using PHASER
and the refined coordinates of GH20A as a search model to find the four mole-
cules in the asymmetric unit. A single GH20B monomer was used as a starting
point to solve the structure of GH20BE805Q by molecular replacement.
Enzyme Kinetics and Inhibition
All steady state kinetic studies were performed at 37C in a Cary/Varian
300 Bio UV-Visible Spectrophotometer. Standard reaction mixtures for the
determination of kinetic constants were done 50 mM citrate buffer, pH 6.0,1612 Structure 19, 1603–1614, November 9, 2011 ª2011 Elsevier Ltdin 1 ml volumes containing 0.43 nM GH20A or 1.0 nM GH20B and 0–1 mM
4-nitrophenyl-N-acetylglucosaminide (pNP-GlcNAc). Mutants of GH20A and
GH20B were assayed at concentrations of 1 nM using pNP-GlcNAc concen-
trations up to 10 mM depending on the mutant. 4-Nitrophenolate production
was monitored at 400 nm; rates were calculated using an extinction coeffi-
cient, ε400nm, of 6090 cm
1 M1. All experiments were performed in triplicate.
Michaelis-Menten parameters were determined by nonlinear curve fitting
using Origin7. The Ki value for GH20A or GH20B inhibition by NGT and
PUGNAc was determined using pNP-GlcNAc as a substrate and by linear
regression analysis of Dixon plots.All rights reserved
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Structural Analysis of StrHIsothermal Titration Calorimetry
Isothermal titration calorimetry (ITC) was performed essentially as described
previously using a VP-ITC system (MicroCal, Northampton, MA) (Ficko-Blean
et al., 2008). Proteins were extensively dialyzed against buffer (50 mM citrate
buffer, pH 6.0) then concentrated in a stirred ultrafiltration cell as above. Inhib-
itor solutions were prepared by mass in buffer saved from the ultrafiltration
step. Protein and inhibitor solutions were filtered and degassed immediately
prior to use. Proteins were used at concentrations of 8–10 mM to ensure
C-values approached 10 or greater. Titrations were performed at 25C. The
data were fit with a single binding site model to determine the dissociation
constant.
Growth Assays
S. pneumoniae TIGR4 (ATCC BAA-334) was used as the parental strain and
routinely cultured from freezer stocks on tryptic soy agar (TSA) supplemented
with 6% (v/v) defibrinated sheep blood (blood agar plate). For the growth
curves, S. pneumoniae was grown on a semidefined media containing
casein hydrolase, salts, vitamins, amino acids, catalase, and albumin
(AGCH) with 0.2% (w/v) yeast extract (AGCHY) (Chan et al., 2003; Lacks,
1966) with the addition of chloramphenicol at 5 mg 3 ml1 when needed.
Unless otherwise stated, S. pneumoniae was grown in a candle jar at 37C
with no shaking. A mutant S. pneumoniae strain, DstrH, was obtained by
a PCR ligation technique to replace the strH gene by a chloramphenicol
cassette using S. pneumoniae TIGR4 as the parental strain (Abbott et al.,
2010; Schell et al., 2002).
The protocol for the growth assays was adapted from Ba¨ttig et al., 2006.
Wild-type and DstrH S. pneumoniae TIGR4 strains were streaked onto blood
agar plates and incubated at 37C in a candle jar for 12 hr. Overnight cultures
were set up by inoculating 10 colonies into AGCHY broth supplemented with
1% (w/v) glucose for 9 hr. The overnight cultures were used to inoculate
fresh AGCHY with 1% (w/v) glucose that were grown until reaching an
OD600 of 0.5–0.6. Cells were then washed with AGCHY broth and subse-
quently diluted 1/50 into AGCHY with an additional 1% (w/v) of glucose or
asialofetuin (ASF), each in triplicate. Optical densities at 600 nm were read
at regular intervals. The half maximal effective concentration (EC50) was deter-
mined graphically.
Opsonophagocytic Killing Assays
Neutrophil killing assays were performed essentially as previously described.
(Dalia et al., 2010; Davis et al., 2008). Briefly, 103 PBS-washed late-log-phase
bacteria (in 10 ml) were preopsonized in 20 ml of a complement source (10%
normal human serum), followed by incubation with 105 neutrophils freshly iso-
lated from human whole blood (40 ml) in 130 ml Hanks balanced salt solution
buffer containing Ca2+ andMg2+ (GIBCO) plus 0.1%gelatin (+++ buffer). Reac-
tion mixtures were then incubated at 37C for 45 min with rotation. Opsono-
phagocytic killing assays were performed with the S. pneumoniae TIGR4
wild-type strain and the DstrH strain in the presence of inhibitors and without
inhibitors where a vehicle control was used instead (+++ buffer). The reactions
were stopped by incubation on ice, and viable counts of bacteria were deter-
mined by dilution plating. Percent survival was determined relative to control
reactions where no neutrophils were added. Statistical significance was
assessed using two-tailed t test comparisons.
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